Hi Jeroe,
Just a few snippets that may help.
Not really sure where the trial stands at this point but probably a bit ambitious to expect revenue at this early stage.
Nomura Research Equities: Nov 2011
Action: MSB has been FDA approved to start a Phase III trial for bone-marrow transplantation.
We believe the trial should run for 12 months, with results available 3-6 months after that. These timelines are within our forecasts for timing of potential revenues for MSB.
We continue to forecast first potential sales for MSB from bone-marrow transplant in FY14.
Jefferies Annual Healthcare Conference
New York 2012
Bone Marrow Transplant Cord Blood Product:
Non-core niche market, FDA-cleared Phase 3 program
EU is the major transplant market, plan for early EU regulatory approval by Q1 2013
Mesoblast
Major Accomplishments
Key operational highlights of the 2011 year:
?Commenced our first Phase 3 trial, for bone marrow transplantation
Australian Stock Report: Oct 2011
Bone marrow approval
Mesoblast recently received approval from US authorities to begin an advanced trial of a treatment that could boost the number of bone marrow transplants for patients who cannot find a matched donor.
Following the approval, MSB has commenced the Phase III trial for bone marrow regeneration in patients with blood cancers.
MSB aims to produce a product that can be used in bone marrow transplants where a perfectly matched donor cannot be found.
Bell Potter 2011
MSB has five Phase II trials underway and is initiating a Phase III trial in Bone Marrow Transplant, with a revenue
opportunity matching that of Cochlear. With the FDA requiring only one Phase II and a pivotal trial before approving a successful stem cell therapy, the company has the potential to be yielding commercial revenues by late 2013.
- Forums
- ASX - By Stock
- MSB
- share price
share price, page-5
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
96.0¢ |
Change
0.025(2.67%) |
Mkt cap ! $1.096B |
Open | High | Low | Value | Volume |
95.0¢ | 96.5¢ | 94.0¢ | $1.231M | 1.291M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 94461 | 95.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
96.0¢ | 61151 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 94461 | 0.950 |
6 | 59977 | 0.945 |
9 | 154571 | 0.940 |
4 | 44875 | 0.935 |
5 | 92633 | 0.930 |
Price($) | Vol. | No. |
---|---|---|
0.960 | 61151 | 6 |
0.965 | 46785 | 5 |
0.970 | 48228 | 6 |
0.975 | 64461 | 2 |
0.980 | 31269 | 3 |
Last trade - 16.10pm 12/09/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |